(UroToday.com) The 2025 ESMO annual meeting featured a metastatic castration-resistant prostate cancer (mCRPC) session and a ...

Clinical Implementation of Expanded Solid Tumor Fusion Detection With Whole-Transcriptome Sequencing at an Academic Cancer Center One hundred twenty-two participants completed the survey. The majority ...

Decipher Prostate Metastatic Genomic Classifier has been launched for use in patients whose prostate cancer has spread beyond the primary tumor, according to a news release from Veracyte, Inc. The ...

A globally-renowned prostate cancer surgeon shares the latest advancements in the field and stresses the importance of early detection.

Founded by Dr. Thomas Crisman, Genome Based Diagnostics has focused on developing accessible and reliable testing solutions ...

For Josh Henderson, 66, of Olympia, getting genetic testing was a no-brainer. “The first time I came to Fred Hutch, my oncologist suggested it,” said the retired IT manager who received a metastatic ...

A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...

The “striking” findings showed an overall upward trend in life expectancy when patients took niraparib - a targeted therapy that blocks cancer cells from repairing their DNA when damaged - alongside ...

Men with genes that increase the risk of prostate cancer should have annual checks from the age of 40, research has shown.

Some 17 million Americans are living with genetic mutations tied to an increased risk of getting cancer, Cleveland Clinic ...